You are here

MannKind Corporation Participating at Upcoming Conferences

WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will be participating at upcoming conferences.
Wednesday, February 20, 2019 - 09:00